Sponsored by:

Molecular Imaging: Page 80

PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 23, 2021
PET links psychological stress and asthma
By Will Morton
PET imaging of brain activity in people with asthma shows that psychological stress is involved in triggering asthma attacks, according to a study published November 17 in Biological Psychology.
November 22, 2021
2021 11 20 01 22 7449 2021 11 23 Pet Stress Asthma 400
Road to RSNA 2021: Molecular Imaging Preview
By Will Morton
Presentations specific to COVID-19 are among the molecular imaging scientific sessions offered at RSNA 2021. Attendees will also enjoy research in oncologic and brain imaging, radionuclide therapy, PET radiopharmaceuticals, technical advances, and more.
November 22, 2021
2017 11 02 17 42 1107 Road To Rsna 400
FDG-PET/CT scans assessed for clinical utility in COVID-19
By Will Morton
Monday, November 29 | 9:30 a.m.-10:30 a.m. | SSNMMI03-4 | Room S402In this talk, researchers will present a study to determine imaging findings and the potential clinical utility of FDG-PET/CT in patients with laboratory-confirmed COVID-19. They suggest FDG-PET/CT scans could be helpful in predicting disease severity.
November 22, 2021
Combining radiomics, AI with PET/MRI helps assess nodal status
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-3 | Room N226Here, researchers will talk about how applying radiomics and machine learning to FDG-PET/MRI can noninvasively assess nodal status and treatment planning for breast cancer patients.
November 22, 2021
PET/MRI shows prowess for nodal staging in breast cancer
By Amerigo Allegretto
Sunday, November 28 | 10:30 a.m.-11:30 a.m. | SSNMMI01-4 | Room N226In this presentation, researchers will compare nodal staging between CT, MRI, and FDG-PET/MRI in patients with newly diagnosed breast cancer.
November 22, 2021
Is FDG uptake normal in patients after ascending aorta replacement?
By Will Morton
Prerecorded, available throughout meeting | SPR-NMMI-16In this presentation, Dutch cardiovascular imaging specialists will discuss interpreting normal F-18 FDG uptake on PET/CT after patients undergo combined aortic valve and ascending aorta replacement.
November 22, 2021
New radiotracer promising for diagnosing infection in vivo
By Will Morton
Prerecorded, available throughout meeting | SPR-NMMI-14In this session exploring new frontiers in PET radiopharmaceuticals, researchers from the University of California, San Francisco will present results from an ongoing trial of a new carbon-11-labeled radiotracer that targets bacterial infection.
November 22, 2021
PET tracer synthesized for imaging cholesterol metabolism
By Will Morton
Thursday, December 2 | 1:30 p.m.-2:30 p.m. | SSNMMI08-1 | Room N228In this presentation, researchers will report a breakthrough after 40 years in the development of a new PET radiotracer for imaging abnormal cholesterol metabolism due to high levels of adrenal aldosterone.
November 22, 2021
PET/MRI assesses ankylosing spondylitis treatment
By Will Morton
Thursday, December 2 | 9:30 a.m.-10:00 a.m. | SSNMMI07-4 | Room E450BF-18 sodium fluoride PET/MR imaging of osteoblastic activity in ankylosing spondylitis patients can assess the effects of anti-tumor necrosis factor therapy, according to German researchers presenting in this session.
November 22, 2021
Antioxidant agent shows promise in reducing DNA damage from radiation
By Will Morton
Tuesday, November 30 | 9:30 a.m.-10:30 a.m. | SSNMMI05-2 | Room E353CIn this session on advances in radionuclide therapy, researchers will present work on the identification and development of an antioxidant agent that may reduce damage to DNA caused by ionizing radiation.
November 22, 2021
PET/CT classifies subtypes in progressive nuclear palsy
By Will Morton
Monday, November 29 | 3:00 p.m.-4:00 p.m. | SSNMMI04-4 | Room S405In this session on brain imaging, researchers from India will present a study that elucidates patterns of characteristic hypometabolism on F-18 FDG PET/CT in various subtypes of progressive nuclear palsy and their correlation with core clinical features.
November 22, 2021
Previous Page
Page 80 of 611
Next Page